AstraZeneca Details New CEO Pay
Linkedin

AstraZeneca Details New CEO Pay

Singapore : Singapore | Oct 29, 2012 at 11:37 AM PDT
Source: Asian Wall Street Journal
XX XX
Views: Pending
 
PLC is awarding its new chief executive, Pascal Soriot, £4 million ($6.44 million) in shares to move from rival Roche Holding AG in compensation for the loss of a long-term incentive package, the company said in a press statement Monday. Dr. Soriot started his job in early October after former Chief... FULL ARTICLE AT Asian Wall Street Journal
1 of 1
AstraZeneca CEO David Brennan said 2010 was going to be a "challenging" year
AstraZeneca CEO David Brennan said 2010 was going to be a "challenging" year
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
Advertisement
 
Advertisement
 

News Stories

 
  • AstraZeneca's new boss set for £11m pay package

    The Independent
    Suggested Topics AstraZeneca has given its new chief executive a pay package worth about £11m, including a £4m "golden hello" to compensate Pascal Soriot for giving up long-term incentives at his previous job. The struggling drugs giant poached Mr...
  • New AstraZeneca chief executive gets £10m package

    Guardian Unlimited
    Pascal Soriot is carrying out a strategy review and will unveil the results to investors at the end of January. Photograph: Reuters AstraZeneca is paying its new chief executive a package worth up to £10m this year, including a "golden hello" of £4m...
  • New AstraZeneca CEO gets $6.4 mn for jumping ship

    The Economic Times
    Struggling British drugmaker AstraZeneca is giving its new chief executive Pascal Soriot 4 million pounds ($6.44 million) compensation for loss of long-term incentives from his previous employer Roche...The pharmaceutical company, which is battling...
  • What Will The New AstraZeneca CEO Get Paid?

    Pharmalot
    Two months ago, AstraZeneca hired Pascal Soriot away from Roche as its new chief executive, following the messy departure by David Brennan, whose compensation was widely criticized as AstraZeneca continued to falter. Now, the drugmaker is making a...

Images

 >
 

More From Allvoices

 
Tap_logo_330_110_event
 


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2013. All rights reserved.